IVVN
Login
Register
Contact
Newsletter
Search
Search
Search
Toggle main menu visibility
About us
Network vision
Network funders
Other Vaccine Networks
Annual Reports
Annual Report 2018
Annual Report 2019
Annual Report 2020
Annual Report 2021
Annual Report 2022
Background
Activities
Structure
Membership
Webinars
Survey results
Outreach
Fellowship programme
Online workshop
Catalyst funding
Equality and inclusivity statement
Members
Membership benefits
Network Management Team
Network Management Board
External Advisory Group
News
Newsletters
Blog
Events
Annual conferences
Nairobi 2018
Hanoi 2020
London 2019
GCRF Networks Vaccinology Course
Presentations
Scholars
Workshops
Past workshops
IVVN Virtual Symposia
IVVN webinars
Training
Online Training Courses
IVVN Early Career Researcher Event
Funding
Pump-priming grants
Funded projects
Laboratory exchange awards
Funded projects
Fellowship programme
Funded projects
Funding opportunities
Privacy statement
Job Vacancies
Publications
Useful Links
Home
Members directory
Members
Members directory
Search
Career stage
Group leader
Postdoc
Postgraduate
Discipline
Bacteriology
Bio-manufacturing
Bioinformatics
Cellular biology
Challenge model development
Challenge study design
Clinical trials – efficacy
Clinical trials – safety
Commercialisation
Deployment
Economics
Epidemiology
Ethics
Formulation technology
Immunology – B-cells
Immunology – T-cells
Immunology – innate
Molecular biology
Parasitology
QC test development
Quality assurance
Registration
Regulation
Safety evaluation
Structural biology
Systems biology
Virology
Host species
Buffalo
Camels
Cats
Cattle
Dogs
Fish
Horses
Pigs
Poultry
Small ruminants
Wildlife
Zoonoses
Pathogen
Adenovirus
Aeromonas
African horse sickness virus
African swine fever virus
Arboviruses
Arteriviruses
Avian papillomavirus
Avian polyomavirus
Babesia
Bacteria
Bluetongue virus
Bovine ephemeral fever virus
Bovine viral diarrhoea
Brucella
Calicivirus
Capripoxvirus
Cestodes
Chicken anaemia virus
Chlamydophila
Classical swine fever virus
Clostridia
Coronavirus
Corynebacterium
Crimean-Congo haemorrhagic fever virus
Cytomegalovirus
E. coli
Ebolaviruses/filoviruses
Eimeria
Erysipelas
Feline leukaemia virus
Foot-and-mouth disease virus
Herpesvirus
Infectious bursal disease virus
Infectious pancreatic necrosis virus
Infectious salmon anaemia virus
Influenza virus
Leptospira
M. hyo
Mareks disease virus
Mycobacteria bovis
Mycoplasma
Nairoviruses
Nematodes
Neospora
Newcastle disease virus
Nipah virus
Parainfluenza virus
Paramyxoviruses
Parasites
Parvovirus
Peste des petits ruminants virus
Piscine novirhabdovirus
Porcine circovirus
Porcine reproductive and respiratory syndrome virus
Poxviruses
Rabies virus
Respiratory syncytial virus
Retroviruses
Rift Valley fever virus
Rotavirus
Salmonella
Taenia solium
Theileria annulata
Theileria parva
Ticks
Trypanosoma
Viruses
Yersinia
Stage of vaccine development
Adjuvants
Antigen discovery and immunogen design
Clinical trials
Commercialisation
Correlates of protection – immunomonitoring
Deployment
Field trials
Marketing
Pre-clinical trials
Vaccine delivery
21 results
ALL
(
-
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Ø
李
Mr
Khrisna
Putera
Head of New Line Business
PT Vaksindo Satwa Nusantara
Pages
« first
‹ previous
1
2
